Literature DB >> 10893154

Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates.

J Bárcena1, A Pagès-Manté, R March, M Morales, M A Ramírez, J M Sánchez-Vizcaíno, J M Torres.   

Abstract

Twenty MV strains obtained from a survey of field strains currently circulating throughout Spain were analyzed for their virulence and horizontal spreading among rabbits by contact transmission. A virus strain with suitable characteristics to be used as a potential vaccine against myxomatosis in wild rabbit populations was selected. Following inoculation, the selected MV strain elicited high levels of MV specific antibodies and induced protection of rabbits against a virulent MV challenge. Furthermore, the attenuated MV was transmitted to 9 out of 16 uninoculated rabbits by contact, inducing protection against myxomatosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893154     DOI: 10.1007/s007050050669

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.

Authors:  J Bárcena; M Morales; B Vázquez; J A Boga; F Parra; J Lucientes; A Pagès-Manté; J M Sánchez-Vizcaíno; R Blasco; J M Torres
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Molecular characterisation of virulence graded field isolates of myxoma virus.

Authors:  Kevin P Dalton; Ines Nicieza; Aroa Baragaño; Jose Manuel Martín Alonso; Francisco Parra
Journal:  Virol J       Date:  2010-02-26       Impact factor: 4.099

3.  Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.

Authors:  Mónica Morales; Miguel A Ramírez; María J Cano; Mario Párraga; Joaquín Castilla; Luis I Pérez-Ordoyo; Juan M Torres; Juan Bárcena
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

Review 4.  The current status and future directions of myxoma virus, a master in immune evasion.

Authors:  Bart Spiesschaert; Grant McFadden; Katleen Hermans; Hans Nauwynck; Gerlinde R Van de Walle
Journal:  Vet Res       Date:  2011-06-09       Impact factor: 3.683

Review 5.  Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.

Authors:  Peter J Kerr; June Liu; Isabella Cattadori; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  Viruses       Date:  2015-03-06       Impact factor: 5.048

6.  Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease.

Authors:  J M Torres; M A Ramírez; M Morales; J Bárcena; B Vázquez; E Espuña; A Pagès-Manté; J M Sánchez-Vizcaíno
Journal:  Vaccine       Date:  2000-09-15       Impact factor: 3.641

7.  Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor.

Authors:  Graham J Belsham; Charlotta Polacek; Solvej Ø Breum; Lars E Larsen; Anette Bøtner
Journal:  Virol J       Date:  2010-01-16       Impact factor: 4.099

Review 8.  Self-disseminating vaccines for emerging infectious diseases.

Authors:  Aisling A Murphy; Alec J Redwood; Michael A Jarvis
Journal:  Expert Rev Vaccines       Date:  2015-11-02       Impact factor: 5.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.